Lung Cancers Completed Phase 1 Trials for Bortezomib (DB00188)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00620295Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid TumorsTreatment
NCT00622674Bortezomib and Cetuximab in Treating Patients With Advanced Solid TumorsTreatment
NCT00667641Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid TumorsTreatment
NCT00388089Bortezomib and Topotecan in Treating Patients With Advanced Solid TumorsTreatment